Table 4. Impact of ILI on health related quality of life for H1N1v confirmed and non-H1N1v ILI control patients.
Confirmed H1N1v ILI cases | ILI controls (non-H1N1v cases) | |
EQ-5D Background (min-max,median) | 0.96 (0.15–1,1) | 0.97 (0.5–1,1) |
EQ-5D Worst day (min-max,median) | 0.29 (−0.073–1,0.24) | 0.34 (−0.073–1,0.24) |
VAS Background (min-max,median) | 90 (20–100,95) | 89 (55–100, 90) |
VAS Worst day (min-max,median) | 30 (0–100,25) | 30 (5–80,30) |
Overall QALY loss (min-max,median) | 0.008 (0–0.027,0.006) | 0.0075 (0–0.044,0.006) |
Overall QALD loss (min-max,median) | 2.92 (0–9.84, 2.18) | 2.74 (0–16.2, 2.12) |